NEW YORK, June 28 - Qiagen and Aventis have signed a technology access agreement for Qiagen's new ZeptoGene Workstation microarray platform, Qiagen said Thursday. 

Under the agreement, Aventis will acquire limited access to the platform, which can be used for both nucleic acid and protein analysis.  

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.